搜索范围
136298
应用筛选条件
关键词:'136298'
显示 1-6 #N/A 6 条结果 关于 "136298" 范围 论文
Shiv K Sharma et al.
Journal of medicinal chemistry, 53(14), 5197-5212 (2010-06-24)
The recently discovered enzyme lysine-specific demethylase 1 (LSD1) plays an important role in the epigenetic control of gene expression, and aberrant gene silencing secondary to LSD1 overexpression is thought to contribute to the development of cancer. We recently reported a
S H Gorman
Journal of chromatography. B, Biomedical sciences and applications, 730(1), 1-7 (1999-08-07)
Modafinil, DL-2-[(diphenylmethyl)sulfinyl]acetamide (Provigil), which is chiral at its sulfur atom, is a novel wake-promoting agent currently being developed as the racemate in the United States by Cephalon, Inc. In order to characterize the pharmacokinetic properties of each enantiomer, a stereospecific
Kun Zhang et al.
Analytica chimica acta, 1144, 34-42 (2021-01-18)
Herein, we report our strategy to develop the efficient chemosensor and real-time monitoring technique for cyanuric chloride (TCT) detection. A luminescent macrocyclic mononuclear Sm(III) complex Sm-2k bearing with two dynamic imine bonds has been constructed via the template synthesis between
T F Holzman et al.
Biochemistry, 20(19), 5524-5528 (1981-09-15)
We have found a new class of inhibitors of the bacterial bioluminescence reaction, the N,N-diphenylalkylamines and acids. We have studied the action of one of these compounds 2,2-diphenylpropylamine. The amine was competitive with the long-chain aliphatic aldehyde substrate (Ki congruent
B Elsenhans et al.
Biochimica et biophysica acta, 813(1), 25-32 (1985-02-28)
Cationic, lipid-soluble organic compounds may interfere with cation-mediated membrane transport processes. Thus, small intestinal absorption may be influenced by lipophilic organic cations. Therefore a series of arylalkylamines was studied in the concentration range from 0.5 to 20 mmol/l for their
A L Mueller et al.
Annals of the New York Academy of Sciences, 890, 450-457 (2000-02-11)
NPS 1506 is a moderate affinity, uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist. NPS 1506 is neuroprotective in rodent models of ischemic stroke, hemorrhagic stroke, and head trauma, with a 2-hr window of opportunity. Neuroprotectant doses of NPS 1506 ranged from approximately
1/1